Protective effects of ghrelin on kidney tissue in rats with partial ureteral obstruction

Protective effects of ghrelin on kidney tissue in rats with partial ureteral obstruction

Background/aim: The aim was to investigate the protective and therapeutic effects of ghrelin, which has antioxidant and antiinflammatoryactivity, on preventing kidney damage that occurs by induced partial ureteral obstruction in rats.Materials and methods: Twenty-eight adult male rats were included in the study, and the rats were divided into 4 groups. After thelaparotomy operation on the sham group, the ureter was identified in the retroperitoneal area and was duly sutured (n = 7). Ghrelinwas administered for seven days intraperitoneally, and after the nephrectomy performed on the 15th day, the rats were sacrificed (n =7). A partial ureteral obstruction was performed after the laparotomy on the PUO group. The rats were sacrificed after the nephrectomyoperation performed on the 15th day (n = 7). A partial ureteral obstruction was formed after the laparotomy followed by seven days ofwaiting in the PUO + ghrelin group. Ghrelin was given in the dose of 10 ng/kg per day intraperitoneally for the next 7 days, and the ratswere sacrificed after the nephrectomy operation performed on the 15th day (n = 7). All groups were evaluated for histological damageand catalase, superoxide dismutase, total glutathione, malondialdehyde, and myeloperoxidase levels were measured in the same tissues.Results: When the 2nd group and the sham group were compared histologically, it was observed that the damage had increased by astatistically significant level in the partial ureteral obstruction group (P = 0.001). When the group which was ghrelin-treated after thepartial ureteral obstruction was compared to the group with just partial ureteral obstruction, the histopathological changes were foundto decrease significantly in that group (P = 0.001). While the statistical significance of the levels of CAT, GSH, and MPO enzymes wasdetected among biochemical changes in the 2nd group when compared to the sham group (P < 0.01), the 3rd group showed a statisticallysignificant difference in the levels of SOD and GSH enzymes compared to the 4th group (P < 0.05).Conclusion: Ghrelin administration to rats after the formation of an experimental partial unilateral ureteral obstruction reduces tissuedamage due to ghrelin’s antiinflammatory and antioxidant effects. Ghrelin administration may prevent tissue damage biochemically andhistopathologically in obstructive uropathy cases.

___

  • 1. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430.
  • 2. Yokoyama H, Tsuji Y. Diuretic Doppler ultrasonography in chronic unilateral partial ureteric obstruction in dogs. BJU Int 2002; 90: 100-104.
  • 3. Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 199; 18: 689-699.
  • 4. Klahr S, Purkerson ML. The pathophysiology of obstructive nephropathy: the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. Am J Kidney Dis 1994; 23: 219-223.
  • 5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
  • 6. Bowers CY. Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab 2001; 86: 1464-1469.
  • 7. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS et al. Ghrelin, a novel growth hormone-releasing acylated peptide is, synthesized in a distinct endocrine cell type in the gastrointestinal tract of rats and humans. Endocrinology 2000; 141: 4255-4261.
  • 8. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522.
  • 9. Aydın S, Özkan Y, Caylak E, Aydın S. Ghrelin and its biochemical functions: review. Türkiye Klinikleri J Med Sci 2006; 26: 272-283 (in Turkish with abstract in English).
  • 10. Aydin S, Aydin S, Ozkan Y, Kumru S. Ghrelin is present in human colostrum, transitional and mature milk. Peptides 2006; 27: 878-882.
  • 11. Kierson JA, Dimatteo DM, Locke RG, Mackley AB, Spear ML. Ghrelin and cholecystokinin in term and preterm human breast milk. Acta Paediatr 2006; 95: 991-995.
  • 12. Aydinli S, Ozercan IH, Dagli F, Aydın S, Kumru S et al. Ghrelin is present in teeth. J. Biochem Mol Biol 2007; 40: 368-372.
  • 13. Aydın S. Ghrelin hormonunun keşfi: araştırmaları ve klinik uygulamaları. Türk Biyokimya Dergisi 2007; 32: 76-89 (in Turkish).
  • 14. Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 2011; 340: 44-58.
  • 15. Takeda R, Nishimatsu H, Suzuki E, Satonaka H, Nagata D et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 113-121.
  • 16. Chung H, Kim E, Lee DH, Seo S, Ju S et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007; 148: 148-159.
  • 17. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037.
  • 18. Ersahin M, Toklu HZ, Erzik C, Cetinel S, Akakin D et al. The antiinflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J Neurotrauma 2010; 27: 1143-1155.
  • 19. Iseri SO, Sener G, Saglam B, Ercan F, Gedik N et al. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept 2008; 146: 73-79.
  • 20. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S et al. Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells. Circulation 2004; 109: 2221-2226.
  • 21. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
  • 22. Sehirli O, Sener E, Sener G, Cetinel S, Erzik C et al. Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines. Peptides 2008; 29: 1231-1240.
  • 23. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-835.
  • 24. Ulm AH, Miller F. An operation to produce experimental reversible hydronephrosis in dogs. J Urol 1962; 88: 337-341.
  • 25. Eddy A. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
  • 26. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S et al. Cell apoptosis and proliferation in experiment chronic obstructive uropathy. Kidney Int 1996; 50: 200-207.
  • 27. Miyajima A, Ito K, Asana T, Seta K, Ueda A et al. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 2001; 166: 1124-1129.
  • 28. Miyajima A, Asano T, Asano T, Yoshimura I, Seta K et al. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 2001; 165: 1714-1718.
  • 29. He P, Li D, Zhang B. Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy. Mol Med Rep 2014; 10: 638-644.
  • 30. Topcu SO, Erbagci A, Erturhan S, Yagci F, Ucak R. Verapamil attenuates renal tubular apoptosis in response to partial unilateral ureteral obstruction. Urol Int 2008; 80: 84-89.
  • 31. Guven B, Gokce M, Saydam O, Can M, Bektas S et al. Effect of ghrelin on inflammatory response in lung contusion. Kaohsiung J Med Sci 2013; 29: 69-74.
  • 32. Lopez NE, Gaston L, Lopez KR, Coimbra RC, Hageny A et al. Early ghrelin treatment attenuates disruption of the blood brain barrier and apoptosis after traumatic brain injury through a UCP-2 mechanism. Brain Res 2012; 13: 140-148.
  • 33. Golestan Jahromi M, Nabavizadeh F, Vahedian J, Nahrevanian H, Dehpour AR et al. Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides 2010; 31: 2114-2117.
  • 34. Alantary AK, Rezk MY, Khaled EAS. Protective effect of ghrelin on paracetamol induced acute hepatotoxicity in rats. J Physiol Pathophysiol 2014; 5: 7-14.
  • 35. Pamukcu O, Kumral ZN, Ercan F, Yegen BC, Ertem D. Antiinflammatory effect of obestatin and ghrelin in dextran sulfate sodium-induced colitis in rats. J Pediatr Gastroenterol Nutr 2013; 57: 211-218.
  • 36. Khowailed A, Younan SM, Ashour H, Kamel AE, Sharawy N. Effects of ghrelin on sepsis-induced acute kidney injury: one step forward. Clin Exp Nephrol 2015; 19: 419-426.
  • 37. Sahin S, Alata O. The role of ghrelin against acute carbon tetrachloride hepatotoxicity in rats. Nobel Med 2013; 9: 43-48.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Protective effects of ghrelin on kidney tissue in rats with partial ureteral obstruction

Seda TAŞDEMİR, Ayla ÖZAYDOĞDU ÇİMEN, Nigar VARDI, Cemal TAŞDEMİR, Serhan ÇİMEN, Burhan ATEŞ

Adem ÇÖBDEN, İsmet Yalkin ÇAMURCU, Serap Bulut ÇÖBDEN, Hakan SOFU, Hanifi ÜÇPUNAR, Ahmet SEVENCAN, Hüseyin DEMİREL

Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies

Burcu AKMAN, Hatice Ayça ATA KORKMAZ, Ahmet SARI

Audiometric threshold shifts after total knee arthroplasty by using gentamicin-loaded bone cement

Hanifi ÜÇPUNAR, Hakan SOFU, Yalkın ÇAMURCU, Adem ÇÖBDEN, Serap BULUT ÇÖBDEN, Hüseyin DEMİREL, Ahmet SEVENCAN

Maja STOJANOVIC, Petar SVORCAN, Aleksandar KARAMARKOVIC, Nebojsa LADJEVIC, Radmilo JANKOVIC, Predrag STEVANOVIC

Is there any difference between endometrial hyperplasia and endometrial carcinoma in terms of expression of TRPM2 and TRPM7 ion channels?

Gökhan ARTAŞ, Şehmus PALA, İlay BURAN, Emre YALÇIN, Ebru ÖNALAN, Remzi ATILGAN, Tuncay KULOĞLU

Nima Montazeri NAJAFABADY, Mohammad Hossein DABBAGHMANESH, Rajeeh MOHAMADIAN-AMIRI, Marzieh BAKHSHAYESHKARAM, Gholamhossein Ranjbar OMRANI

Alis KOSTANOĞLU, Meltem RAMOĞLU, Ethem GÜNEREN

Optimum recording time of routine electroencephalogram for adults with epilepsy

Yılmaz ÇETİNKAYA, Kemal TUTKAVUL

The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia

Haner DİRESKENELİ, Levent KILIÇ, Umut KALYONCU, Kenan AKSU, Fatih YILDIZ, Cemal BES, Veli YAZISIZ, Emel GÖNÜLLÜ, Dilek SOLMAZ, Sedat YILMAZ, Gözde YILDIRIM ÇETİN, Hakan EMMUNGİL, Servet AKAR, Timuçin KAŞİFOĞLU, Sema YILMAZ, Yavuz PEHLİVAN, İsmail SARI, Şükran ERTEN, Soner ŞENEL, Fezan ŞAHİN, Sibel Y